Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.

Blair, John E A

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. [electronic resource] - Journal of the American College of Cardiology Nov 2008 - 1640-8 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1558-3597

10.1016/j.jacc.2008.07.056 doi


Aged
Aged, 80 and over
Benzazepines--therapeutic use
Double-Blind Method
Female
Heart Failure--drug therapy
Hospitalization
Humans
Internationality
Kaplan-Meier Estimate
Male
Middle Aged
Myocardial Revascularization
Pacemaker, Artificial--statistics & numerical data
Prospective Studies
Tolvaptan
Vasopressins--antagonists & inhibitors